Research Article
Fibrin Clot Strength in Patients with Diabetes Mellitus Measured by Thrombelastography
Figure 2
Correlation between whole blood and platelet-poor plasma TEG measurements in a subgroup of the overall study population () divided between subjects with and without diabetes mellitus. (a) TEG-R: time to fibrin formation. (b) TEG-K: clot formation time. (c) TEG-MA: maximal clot strength.
(a) |
(b) |
(c) |